Omnicell Inc (OMCL)

$34.37 -0.45 (-1.29%)
Market Cap 1.56B
Revenue (ttm) 1.18B
Net Income (ttm) 2.05M
EPS (ttm) N/A
PE Ratio 22.32
Forward PE 24.38
Profit Margin 0.17%
Debt to Equity Ratio 0.00
Volume 873,100
Avg Vol 772,156
Day's Range N/A - N/A
Shares Out 45.48M
Stochastic %K 60%
Beta 0.97
Analysts Strong Sell
Price Target $55.00

Company Profile

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medicat...

Industry: Health Information Services
Sector: Healthcare
Phone: 877 415 9990
Address:
4220 North Freeway, Fort Worth, United States
TNNStockAnalysisNews
TNNStockAnalysisNews Sep. 4 at 1:01 AM
Stocks to Watch Tomorrow, Sep 4, 2026: $BWIN — Up 57% in a Month, Testing Analyst Conviction $OMCL — Pharmacy Automation Play With a Wide Analyst Target Gap $FRPT — A “Pet Humanization” Play With 50% Implied Upside $MRAM — A Diversified Memory Play at the AI Supply Chain’s Edge Small-Cap Digital Asset Treasury Basket — A Fresh Crypto Mining Theme Still Under $2 Billion https://truthsandnews.com/markets/10-stocks-to-watch-tomorrow-sept-4-2026-small-cap-movers
0 · Reply
MGAP
MGAP Aug. 15 at 5:37 PM
$ONFO follow this guy. Accurate . Stock went up 200% Friday $SXTP $WMT $OMCL
1 · Reply
EarningsInsider
EarningsInsider Jul. 31 at 5:01 AM
https://www.marketbeat.com/earnings/reports/2026-7-30-omnicell-inc-stock/ $OMCL Omnicell Earnings Transcript
0 · Reply
Estimize
Estimize Jul. 30 at 11:04 PM
$OMCL reported 0.94 EPS and 312.21 revenue for Q2. http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_content=OMCL&utm
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 30 at 12:30 PM
$OMCL (-11.9% pre) Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance https://ooc.bz/l/109282
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 30 at 10:41 AM
$OMCL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 up 341.67% YoY • Reported revenue of $312.21M up 7.45% YoY • Omnicell, Inc. updated its full year 2026 guidance, tightening revenue ranges to $1.225 billion - $1.245 billion while raising non-GAAP EBITDA to $175 million - $185 million and non-GAAP EPS to $2.15 - $2.30.
0 · Reply
AlexSwiss77
AlexSwiss77 Jul. 21 at 9:06 PM
$OMCL adding low 40s
0 · Reply
HumblKing
HumblKing May. 21 at 4:30 PM
$OMCL fda says the device kills you
2 · Reply
theoptionsplug
theoptionsplug May. 21 at 4:30 PM
$OMCL on gap fill watch 🔻
0 · Reply
theoptionsplug
theoptionsplug May. 21 at 4:28 PM
$OMCL gets FDA warning on product use ⚠️
1 · Reply
Latest News on OMCL
Omnicell, TraceLink integrate DSCSA solution into hospital pharmacy operations

2026-09-03T14:10:22.000Z - 4 days ago

Omnicell, TraceLink integrate DSCSA solution into hospital pharmacy operations

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

Sep 3, 2026, 10:00 AM EDT - 4 days ago

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

Omnicell management to meet with Piper Sandler

2026-08-31T20:35:29.000Z - 7 days ago

Omnicell management to meet with Piper Sandler

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

Aug 31, 2026, 4:01 PM EDT - 7 days ago

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

Omnicell management to meet with KeyBanc

2026-08-17T08:58:48.000Z - 21 days ago

Omnicell management to meet with KeyBanc

Omnicell management to meet virtually with Freedom Capital

2026-08-06T19:35:54.000Z - 4 weeks ago

Omnicell management to meet virtually with Freedom Capital

Omnicell price target lowered to $45 from $55 at Piper Sandler

2026-08-03T11:31:33.000Z - 5 weeks ago

Omnicell price target lowered to $45 from $55 at Piper Sandler

Omnicell price target lowered to $65 from $70 at KeyBanc

2026-07-31T11:11:40.000Z - 5 weeks ago

Omnicell price target lowered to $65 from $70 at KeyBanc

Omnicell price target lowered to $50 from $55 at Wells Fargo

2026-07-31T11:01:03.000Z - 5 weeks ago

Omnicell price target lowered to $50 from $55 at Wells Fargo

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Jul 30, 2026, 4:01 PM EDT - 5 weeks ago

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Omnicell Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 5 weeks ago

Omnicell Earnings Call Transcript: Q2 2026

Omnicell Earnings release: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 5 weeks ago

Omnicell Earnings release: Q2 2026

Omnicell Slides: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 5 weeks ago

Omnicell Slides: Q2 2026

Omnicell Quarterly report: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 5 weeks ago

Omnicell Quarterly report: Q2 2026

Omnicell reports Q2 non-GAAP EPS 94c, consensus 47c

2026-07-30T11:23:44.000Z - 5 weeks ago

Omnicell reports Q2 non-GAAP EPS 94c, consensus 47c

Omnicell sees Q3 non-GAAP EPS 35c-43c, consensus 47c

2026-07-30T11:23:14.000Z - 5 weeks ago

Omnicell sees Q3 non-GAAP EPS 35c-43c, consensus 47c

Omnicell sees 2026 non-GAAP EPS $2.15-$2.30, consensus $1.94

2026-07-30T11:22:51.000Z - 5 weeks ago

Omnicell sees 2026 non-GAAP EPS $2.15-$2.30, consensus $1.94

Omnicell Announces Second Quarter 2026 Financial Results

Jul 30, 2026, 6:30 AM EDT - 5 weeks ago

Omnicell Announces Second Quarter 2026 Financial Results

Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

Jul 13, 2026, 4:01 PM EDT - 1 month ago

Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

Omnicell appoints Njoku as President of the Company

2026-07-01T12:20:10.000Z - 2 months ago

Omnicell appoints Njoku as President of the Company

Nnamdi Njoku Appointed President of Omnicell

Jul 1, 2026, 8:15 AM EDT - 2 months ago

Nnamdi Njoku Appointed President of Omnicell

Omnicell Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 3:20 PM EDT - 3 months ago

Omnicell Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Omnicell appoints Dan Mandoli as GM, Specialty Pharmacy Services

2026-06-08T12:41:28.000Z - 3 months ago

Omnicell appoints Dan Mandoli as GM, Specialty Pharmacy Services

Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business

Jun 8, 2026, 8:30 AM EDT - 3 months ago

Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business

Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 2, 2026, 4:01 PM EDT - 3 months ago

Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Omnicell management to meet with Craig-Hallum

2026-05-26T20:45:34.000Z - 3 months ago

Omnicell management to meet with Craig-Hallum

Omnicell announces removal of i.vSTATION syringe labels

2026-05-21T16:45:43.000Z - 3 months ago

Omnicell announces removal of i.vSTATION syringe labels

Omnicell Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 11:40 AM EDT - 3 months ago

Omnicell Transcript: Bank of America Global Healthcare Conference 2026

Omnicell to Present at the BofA Securities 2026 Healthcare Conference

May 4, 2026, 4:01 PM EDT - 4 months ago

Omnicell to Present at the BofA Securities 2026 Healthcare Conference

Omnicell price target raised to $55 from $53 at Craig-Hallum

2026-04-29T16:43:00.000Z - 4 months ago

Omnicell price target raised to $55 from $53 at Craig-Hallum

Omnicell appoints Rick Couldry as SVP, chief pharmacy and clinical officer

2026-04-29T15:17:54.000Z - 4 months ago

Omnicell appoints Rick Couldry as SVP, chief pharmacy and clinical officer

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer

Omnicell price target raised to $70 from $60 at KeyBanc

2026-04-29T11:01:22.000Z - 4 months ago

Omnicell price target raised to $70 from $60 at KeyBanc

Omnicell price target raised to $70 from $60 at KeyBanc

2026-04-28T17:15:43.000Z - 4 months ago

Omnicell price target raised to $70 from $60 at KeyBanc

Omnicell Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Omnicell Earnings Call Transcript: Q1 2026

Omnicell Earnings release: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Omnicell Earnings release: Q1 2026

Omnicell Slides: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Omnicell Slides: Q1 2026

Omnicell Quarterly report: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Omnicell Quarterly report: Q1 2026

Omnicell reports Q1 adjusted EPS 55c, consensus 33c

2026-04-28T10:46:03.000Z - 4 months ago

Omnicell reports Q1 adjusted EPS 55c, consensus 33c

Omnicell Announces First Quarter 2026 Financial Results

Apr 28, 2026, 6:30 AM EDT - 4 months ago

Omnicell Announces First Quarter 2026 Financial Results

Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

Apr 13, 2026, 5:00 PM EDT - 4 months ago

Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

Omnicell Proxy statement: Proxy filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Omnicell Proxy statement: Proxy filing

Omnicell Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Omnicell Proxy statement: Proxy filing

Omnicell Earnings Call Transcript: Q4 2025

Feb 5, 2026, 8:30 AM EST - 7 months ago

Omnicell Earnings Call Transcript: Q4 2025

Omnicell Annual report: Q4 2025

Feb 5, 2026, 8:30 AM EST - 7 months ago

Omnicell Annual report: Q4 2025

Omnicell Earnings release: Q4 2025

Feb 5, 2026, 8:30 AM EST - 7 months ago

Omnicell Earnings release: Q4 2025

Omnicell Slides: Q4 2025

Feb 5, 2026, 8:30 AM EST - 7 months ago

Omnicell Slides: Q4 2025

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Feb 5, 2026, 6:30 AM EST - 7 months ago

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Jan 13, 2026, 8:01 AM EST - 7 months ago

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Omnicell Transcript: Investor Update

Dec 8, 2025, 7:00 PM EST - 9 months ago

Omnicell Transcript: Investor Update

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Dec 8, 2025, 8:00 AM EST - 9 months ago

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Omnicell Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 1:00 PM EST - 9 months ago

Omnicell Transcript: Piper Sandler 37th Annual Healthcare Conference

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Dec 1, 2025, 4:01 PM EST - 9 months ago

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 4:01 PM EST - 9 months ago

Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

Nov 13, 2025, 8:00 AM EST - 9 months ago

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

Omnicell Earnings Call Transcript: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 10 months ago

Omnicell Earnings Call Transcript: Q3 2025

Omnicell Quarterly report: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 10 months ago

Omnicell Quarterly report: Q3 2025

Omnicell Earnings release: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 10 months ago

Omnicell Earnings release: Q3 2025

Omnicell Slides: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 10 months ago

Omnicell Slides: Q3 2025

Omnicell Slides: Investor Presentation

Oct 30, 2025, 8:00 AM EDT - 10 months ago

Omnicell Slides: Investor Presentation

Omnicell Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 6:30 AM EDT - 10 months ago

Omnicell Announces Third Quarter 2025 Financial Results

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

Oct 6, 2025, 4:01 PM EDT - 11 months ago

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer

Aug 25, 2025, 4:05 PM EDT - 1 year ago

Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer

Omnicell Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q2 2025

Omnicell Quarterly report: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Omnicell Quarterly report: Q2 2025

Omnicell Earnings release: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Omnicell Earnings release: Q2 2025

Omnicell Slides: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Omnicell Slides: Q2 2025

Omnicell Announces Second Quarter 2025 Results

Jul 31, 2025, 6:30 AM EDT - 1 year ago

Omnicell Announces Second Quarter 2025 Results

Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025

Jul 14, 2025, 4:01 PM EDT - 1 year ago

Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

May 22, 2025, 8:30 AM EDT - 1 year ago

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

Omnicell Announces New Products for Perioperative and Clinic Settings

May 14, 2025, 4:01 PM EDT - 1 year ago

Omnicell Announces New Products for Perioperative and Clinic Settings

Omnicell Opens New Innovation Lab in Austin, Texas

May 14, 2025, 8:30 AM EDT - 1 year ago

Omnicell Opens New Innovation Lab in Austin, Texas

Omnicell Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q1 2025

Omnicell Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Omnicell Quarterly report: Q1 2025

Omnicell Earnings release: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Omnicell Earnings release: Q1 2025

Omnicell Slides: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Omnicell Slides: Q1 2025

Omnicell Announces First Quarter 2025 Results

May 6, 2025, 6:30 AM EDT - 1 year ago

Omnicell Announces First Quarter 2025 Results

Omnicell Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Omnicell Proxy statement: Proxy Filing

Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer

Mar 24, 2025, 4:01 PM EDT - 1 year ago

Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer

Omnicell Announces Chief Financial Officer Transition

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Omnicell Announces Chief Financial Officer Transition

Omnicell Earnings Call Transcript: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

Omnicell Earnings Call Transcript: Q4 2024

Omnicell Annual report: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

Omnicell Annual report: Q4 2024

Omnicell Earnings release: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

Omnicell Earnings release: Q4 2024

Omnicell Slides: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

Omnicell Slides: Q4 2024

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

Feb 6, 2025, 6:30 AM EST - 1 year ago

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

Omnicell Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 4:30 PM EST - 1 year ago

Omnicell Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Jan 13, 2025, 5:47 PM EST - 1 year ago

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 4:01 PM EST - 1 year ago

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Omnicell Announces OmniSphere

Dec 9, 2024, 8:30 AM EST - 1 year ago

Omnicell Announces OmniSphere

Omnicell Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 2:00 PM EST - 1 year ago

Omnicell Transcript: Piper Sandler 36th Annual Healthcare Conference

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 22, 2024, 4:01 PM EST - 1 year ago

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

Nov 20, 2024, 2:00 AM EST - 1 year ago

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes

Nov 18, 2024, 4:12 PM EST - 1 year ago

Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes

Omnicell Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q3 2024

Omnicell Quarterly report: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Omnicell Quarterly report: Q3 2024

Omnicell Earnings release: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Omnicell Earnings release: Q3 2024

Omnicell Slides: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Omnicell Slides: Q3 2024

Omnicell Announces Third Quarter 2024 Results

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Third Quarter 2024 Results

Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 7, 2024, 5:35 PM EDT - 1 year ago

Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024

Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer

Sep 25, 2024, 4:01 PM EDT - 1 year ago

Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer

Omnicell Transcript: 2024 Wells Fargo Healthcare Conference

Sep 5, 2024, 1:30 PM EDT - 2 years ago

Omnicell Transcript: 2024 Wells Fargo Healthcare Conference

Omnicell Announces Central Med Automation Service

Aug 20, 2024, 4:30 PM EDT - 2 years ago

Omnicell Announces Central Med Automation Service

Omnicell to Present at the 2024 Wells Fargo Healthcare Conference

Aug 15, 2024, 4:01 PM EDT - 2 years ago

Omnicell to Present at the 2024 Wells Fargo Healthcare Conference

Omnicell Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Omnicell Earnings Call Transcript: Q2 2024

Omnicell Quarterly report: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Omnicell Quarterly report: Q2 2024

Omnicell Earnings release: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Omnicell Earnings release: Q2 2024

Omnicell Slides: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Omnicell Slides: Q2 2024

Omnicell Announces Second Quarter 2024 Results

Aug 1, 2024, 6:30 AM EDT - 2 years ago

Omnicell Announces Second Quarter 2024 Results

Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 15, 2024, 4:01 PM EDT - 2 years ago

Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024

Omnicell Transcript: BofA Securities 2024 Health Care Conference

May 15, 2024, 6:40 PM EDT - 2 years ago

Omnicell Transcript: BofA Securities 2024 Health Care Conference

Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation

May 6, 2024, 4:23 PM EDT - 2 years ago

Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation

Omnicell to Present at the BofA Securities 2024 Health Care Conference

May 3, 2024, 4:01 PM EDT - 2 years ago

Omnicell to Present at the BofA Securities 2024 Health Care Conference

Omnicell Earnings Call Transcript: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

Omnicell Earnings Call Transcript: Q1 2024

Omnicell Quarterly report: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

Omnicell Quarterly report: Q1 2024

Omnicell Earnings release: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

Omnicell Earnings release: Q1 2024

Omnicell Slides: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

Omnicell Slides: Q1 2024

Omnicell Announces First Quarter 2024 Results

May 2, 2024, 7:30 AM EDT - 2 years ago

Omnicell Announces First Quarter 2024 Results

Omnicell Announces XT Amplify

Apr 16, 2024, 4:01 PM EDT - 2 years ago

Omnicell Announces XT Amplify

Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024

Apr 8, 2024, 4:01 PM EDT - 2 years ago

Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024

Omnicell Proxy statement: Proxy Filing

Apr 4, 2024, 8:00 AM EDT - 2 years ago

Omnicell Proxy statement: Proxy Filing

Omnicell Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 20, 2024, 4:30 PM EDT - 2 years ago

Omnicell Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum

Mar 11, 2024, 5:11 PM EDT - 2 years ago

Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum

Omnicell Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Omnicell Earnings Call Transcript: Q4 2023

Omnicell Annual report: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Omnicell Annual report: Q4 2023

Omnicell Earnings release: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Omnicell Earnings release: Q4 2023

Omnicell Slides: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Omnicell Slides: Q4 2023

Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results

Feb 8, 2024, 8:00 AM EST - 2 years ago

Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results

TNNStockAnalysisNews
TNNStockAnalysisNews Sep. 4 at 1:01 AM
Stocks to Watch Tomorrow, Sep 4, 2026: $BWIN — Up 57% in a Month, Testing Analyst Conviction $OMCL — Pharmacy Automation Play With a Wide Analyst Target Gap $FRPT — A “Pet Humanization” Play With 50% Implied Upside $MRAM — A Diversified Memory Play at the AI Supply Chain’s Edge Small-Cap Digital Asset Treasury Basket — A Fresh Crypto Mining Theme Still Under $2 Billion https://truthsandnews.com/markets/10-stocks-to-watch-tomorrow-sept-4-2026-small-cap-movers
0 · Reply
MGAP
MGAP Aug. 15 at 5:37 PM
$ONFO follow this guy. Accurate . Stock went up 200% Friday $SXTP $WMT $OMCL
1 · Reply
EarningsInsider
EarningsInsider Jul. 31 at 5:01 AM
https://www.marketbeat.com/earnings/reports/2026-7-30-omnicell-inc-stock/ $OMCL Omnicell Earnings Transcript
0 · Reply
Estimize
Estimize Jul. 30 at 11:04 PM
$OMCL reported 0.94 EPS and 312.21 revenue for Q2. http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_content=OMCL&utm
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 30 at 12:30 PM
$OMCL (-11.9% pre) Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance https://ooc.bz/l/109282
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 30 at 10:41 AM
$OMCL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 up 341.67% YoY • Reported revenue of $312.21M up 7.45% YoY • Omnicell, Inc. updated its full year 2026 guidance, tightening revenue ranges to $1.225 billion - $1.245 billion while raising non-GAAP EBITDA to $175 million - $185 million and non-GAAP EPS to $2.15 - $2.30.
0 · Reply
AlexSwiss77
AlexSwiss77 Jul. 21 at 9:06 PM
$OMCL adding low 40s
0 · Reply
HumblKing
HumblKing May. 21 at 4:30 PM
$OMCL fda says the device kills you
2 · Reply
theoptionsplug
theoptionsplug May. 21 at 4:30 PM
$OMCL on gap fill watch 🔻
0 · Reply
theoptionsplug
theoptionsplug May. 21 at 4:28 PM
$OMCL gets FDA warning on product use ⚠️
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 4:20 PM
$OMCL Current Stock Price: $43.01 Contracts to trade: $45.0 OMCL May 15 2026 Call Entry: $0.50 Exit: $0.81 ROI: 63% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize May. 4 at 1:09 PM
Wall St is expecting 0.47 EPS for $OMCL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
0 · Reply
BearLurker
BearLurker May. 3 at 4:48 AM
$OMCL Healthcare technology company with steady demand; growth depends on adoption and margins
0 · Reply
Charterdi3
Charterdi3 May. 2 at 5:11 PM
$OMCL $UNH $ROK $BTC.X #Mining #Earnings ‼️🔥‼️ Can we get research on the table #Investment terminology 😫😔😛
0 · Reply
souldout
souldout Apr. 29 at 11:55 AM
$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 2:05 PM
Top Gainers PT2 $SNBR $JSPRW $POM $SANM $OMCL
0 · Reply
Alvi722
Alvi722 Apr. 28 at 1:53 PM
$OMCL could be a good short candidate , dangerous though since low shares. @cubie
1 · Reply
AlphaBull_10M
AlphaBull_10M Apr. 28 at 1:52 PM
Pre market gainers led by $OMCL $DDI $KNSA $AXGN $SEI
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 28 at 12:28 PM
$OMCL (+21.4% pre) Hospital demand helps Omnicell swing from loss to $11M profit https://ooc.bz/l/100173
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 12:15 PM
Pre Market Top Gainers $SAFX $KIDZ $DRCT $SKYQ $OMCL
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 28 at 10:43 AM
$OMCL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.25 up 266.67% YoY • Reported revenue of $309.88M up 14.91% YoY • Omnicell is increasing its full year 2026 non-GAAP EBITDA guidance to $153 million to $168 million and non-GAAP earnings per share to $1.80 to $2.00, with total revenues projected between $1.215 billion and $1.255 billion.
0 · Reply